These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4040949)

  • 1. [A study of the properties of human chorionic gonadotropin (hCG) from total hydatidiform mole with low hCG immunoactivity].
    Imamichi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1205-14. PubMed ID: 4040949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and physicochemical properties of human chorionic gonadotropin of hydatidiform mole.
    Imamura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1631-6. PubMed ID: 7240828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and comparison of two forms of human chorionic gonadotropin from hydatidiform moles with low and high immunoreactivity.
    Imamura S; Imamichi S; Yamabe T; Ishiguro M
    Am J Obstet Gynecol; 1985 Jan; 151(1):136-41. PubMed ID: 3966497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues.
    Yoshimura M; Pekary AE; Pang XP; Berg L; Goodwin TM; Hershman JM
    J Clin Endocrinol Metab; 1994 Apr; 78(4):862-6. PubMed ID: 8157712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
    Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissue.
    Osathanondh R; Elkind-Hirsch KE
    Placenta Suppl; 1981; 3():257-61. PubMed ID: 6763999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin levels in complete and partial hydatidiform moles and in nonmolar abortuses.
    Smith EB; Szulman AE; Hinshaw W; Tyrey L; Surti U; Hammond CB
    Am J Obstet Gynecol; 1984 May; 149(2):129-32. PubMed ID: 6720790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressive effect of human chorionic gonadotropin of various preparations on lymphocyte blastogenesis in vitro.
    Huang HJ
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1062-70. PubMed ID: 7304131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of choriogonadotropin from hydatidiform mole.
    Choy YM; Lau KM; Ma PH; Lee CY
    Clin Chim Acta; 1978 Apr; 85(1):7-15. PubMed ID: 417881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased in vitro thyrotropic activity of partially sialated human chorionic gonadotropin extracted from hydatidiform moles of patients with hyperthyroidism.
    Pekary AE; Jackson IM; Goodwin TM; Pang XP; Hein MD; Hershman JM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):70-4. PubMed ID: 8421106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in complete hydatidiform mole.
    Sukcharoen N; Mutirangura A; Limpongsanurak S
    J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures, function, and transformational changes of the sugar chains of glycohormones.
    Kobata A
    J Cell Biochem; 1988 May; 37(1):79-90. PubMed ID: 2839526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of incompletely sialylated human chorionic gonadotropin by peanut agglutinin in choriocarcinoma.
    Nishimura R; Mizuochi T; Utsunomiya T; Ide K; Kobata A; Mochizuki M
    Jpn J Exp Med; 1985 Apr; 55(2):75-8. PubMed ID: 4046212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors.
    Mann K; Schneider N; Hoermann R
    Endocrinology; 1986 Apr; 118(4):1558-66. PubMed ID: 3004921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.